Lv72
4040 积分 2021-10-14 加入
A silver lining on the horizon for glioblastoma
2天前
已完结
Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma
10天前
已完结
Global patterns and trends in breast cancer incidence and mortality across 185 countries
15天前
已完结
Inflammatory Bowel Disease
22天前
已完结
VHL Inactivation in Renal Cell Carcinoma: Implications for Diagnosis, Prognosis, and Treatment
22天前
已关闭
Targeting HIF-2 Alpha in Renal Cell Carcinoma
22天前
已完结
Targeting the HIF2–VEGF axis in renal cell carcinoma
22天前
已完结
Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma
27天前
已关闭
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
28天前
已完结
Risankizumab versus ustekinumab for Crohn’s disease: a phase IIIb study
28天前
已完结
皖公网安备34019202002308
